THE USE OF ANALGESICS, SEDATIVE MEDICATIONS AND MUSCLE RELAXANTS IN CHILDREN - PowerPoint PPT Presentation

1 / 58
About This Presentation
Title:

THE USE OF ANALGESICS, SEDATIVE MEDICATIONS AND MUSCLE RELAXANTS IN CHILDREN

Description:

CHERI LANDERS, M.D. University of Kentucky LYNNE W. COULE, M.D. Medical College of Georgia Why sedate a child? improve patient tolerance of procedures, invasive ... – PowerPoint PPT presentation

Number of Views:216
Avg rating:3.0/5.0
Slides: 59
Provided by: LynneW3
Category:

less

Transcript and Presenter's Notes

Title: THE USE OF ANALGESICS, SEDATIVE MEDICATIONS AND MUSCLE RELAXANTS IN CHILDREN


1
THE USE OF ANALGESICS, SEDATIVE MEDICATIONS AND
MUSCLE RELAXANTS IN CHILDREN
  • CHERI LANDERS, M.D.
  • University of Kentucky
  • LYNNE W. COULE, M.D.
  • Medical College of Georgia

2
Why sedate a child?
  • improve patient tolerance of procedures, invasive
    monitors and unfamiliar environments
  • airway control
  • decrease the work of breathing
  • decrease oxygen demand
  • reduce anxiety and pain

3
Examples
  • Procedures
  • Radiologic Imaging
  • Bone marrow aspiration
  • Minor surgical procedures
  • PIC/deep line placement
  • Decrease agitation while on mechanical
    ventilation
  • Facilitate air exchange in severe asthma
  • Decrease oxygen demand in septic shock

4
Analgesia/Sedation Myths and Concerns
  • Children dont feel pain/anxiety like adults
  • Respiratory depression
  • Hemodynamic compromise
  • Addiction

5
Analgesia/Sedation Myth
  • Children DO feel pain/anxiety
  • Anatomy
  • Myelinated and unmyelinated fibers transmit
    electrical impulse
  • Impulse travels faster when myelinated
  • Psychological

6
Analgesia/Sedation Concerns
  • Respiratory depression
  • Receptor based phenomenon
  • Need to titrate
  • Caveat in the lt 6 month old infant
  • Opioids can cause apnea prior to pain relief

7
Analgesia/Sedation Concerns
  • Addiction
  • Addiction vs. Tolerance vs. Dependance

8
Addiction
  • A common fear voiced by parents
  • Less common in hospitalized patients than in the
    general population
  • Includes a psychological need or craving along
    with physical withdrawal symptoms if medication
    is discontinued

9
Tolerance
  • The same dose of medication no longer has the
    same effect as when first started
  • More commonly occurs in patients on long term
    continuous infusions of sedatives or analgesics
    rather than intermittent dosing

10
Dependence
  • Removing medication results in withdrawal
    symptoms
  • To avoid withdrawal, may need to wean sedative or
    analgesic when patient has been on the medication
    for 1 week or more

11
What is sedation?
12
Continuum of Consciousness
General anesthesia
Awake, baseline
Conscious sedation
Drowsy
Deep sedation
13
Level of Sedation Required
  • In general, the younger the child and the lower
    their cognitive abilities, the more deeply
    sedated they will need to be to accomplish the
    same procedural goal

14
Conscious Sedation
  • A medically controlled state of depressed
    consciousness that allows reflex ability to
    maintain a patent airway, and permits appropriate
    neurological responses to verbal stimuli.

15
Deep Sedation
  • A medically controlled state of depressed
    consciousness or unconsciousness from which a
    patient is not easily aroused. It may be
    accompanied by a loss of protective reflexes and
    includes an inability to maintain a patent
    airway and respond appropriately to stimuli.

16
Benzodiazepines
  • Bind CNS GABA receptors
  • Skeletal muscle relaxation
  • Amnesia
  • Antegrade and retrograde
  • Anxiolysis
  • Respiratory Depression

17
Midazolam (Versed)
  • Advantages
  • anxiolysis, sedation, motion control
  • retrograde amnesia
  • PO, IV, IM, IN, PR dosing routes
  • onset 2-6 min after IV administration, 45-60 min
    duration
  • available reversal agent
  • Flumazenil

18
Midazolam (Versed)
  • Disadvantages
  • No analgesia
  • Paradoxical reactions
  • More than additive risk of respiratory compromise
    when added to opiate
  • Neonates hypotension and seizures with rapid
    injection
  • Peak serum level increased with itraconazole,
    erythromycin and clarithromycin

19
Barbiturates
  • General CNS depressants
  • Induction of anesthesia
  • Hypnosis
  • Sedation
  • Respiratory depression

20
Pentobarbital (Nembutal)
  • Advantages
  • Fairly safe
  • Sedation, motion control, anxiolysis
  • Short onset (3-5 min. given IV) and duration
    (15-45 min.)
  • Alternative to chloral hydrate in older children
  • PO, IV, IM, PR dosing routes
  • longer time to onset and longer duration with
    routes other than IV

21
Pentobarbital
  • Disadvantages
  • Enhances pain perception
  • No reversal agent

22
Chloral Hydrate
  • Advantages
  • PO, PR dosing
  • initial 25-100 mg/kg
  • repeat after 30 min if need 25-50 mg/kg
  • Anxiolysis, sedation, motion control
  • Single dose toxicity is low
  • Successful in younger patients (lt 2-3 yrs)
  • Many practitioners familiar with its use

23
Chloral Hydrate
  • Disadvantages
  • 15-30 min to onset, lasts 1-2 hours
  • Less successful in older children
  • High doses can cause respiratory depression and
    dysrhythmias
  • No pain control
  • Not reversible
  • Repetitive doses cause metabolites to accumulate
    with unknown toxicities

24
What is pain?
  • Physical or mental suffering or distress

25
Two components of pain
  • Physical stimulus
  • Affective response

26
Analgesia
  • I cant think of any other area in medicine in
    which such an extravagant concern for side
    effects so drastically limits treatment.
  • M. Angell. The quality of mercy. NEJM, 1982306.

27
What is Analgesia?
  • Relief of the perception of pain without
    intentional production of a sedated state.
    Altered mental status may be a secondary effect
    of medications administered for this purpose.

28
Local analgesia for procedures
  • EMLA Cream
  • Apply to intact skin with occlusive dressing
    30-60 min prior to procedure
  • Buffered Lidocaine
  • (1 ml bicarb/9 ml 1 lidocaine)
  • Maximum dose lidocaine
  • 4.5 mg/kg without epinephrine
  • 7 mg/kg with epinephrine

29
Narcotic Analgesics
  • Activate descending CNS tracts
  • Sedation
  • Analgesia
  • Respiratory depression
  • Moderate anxiolysis

30
Fentanyl
  • Opioid
  • Advantages
  • analgesia
  • 100x more potent than morphine
  • shorter duration than morphine
  • onset in 2-3 min, lasts 30-60 min
  • less histamine release than morphine
  • available reversal agent
  • naloxone

31
Fentanyl
  • Disadvantages
  • no amnesia
  • Steel chest or rigid chest phenomenon
  • more likely with large bolus dose
  • Treat with reversal of fentanyl or paralyzation

32
Morphine
  • Opioid
  • Advantages
  • Analgesia
  • Less expensive than fentanyl
  • Disadvantages
  • no amnesia, anxiolysis
  • Histamine release - wheezing, hypotension
  • Longer onset than other opioids

33
Ketamine
  • Dissociative anesthetic
  • Advantages
  • provides both analgesia and amnesia
  • preserves upper airway tone and reflexes
  • causes bronchodilatation

34
Ketamine
  • Disadvantages
  • increases intracranial pressure
  • laryngospasm
  • hypersecretory response
  • parents disturbed by blank stare
  • emergence phenomenon/agitation

35
Ketamine
  • Relative contraindications
  • head injury
  • airway abnormalities
  • procedures where posterior pharynx will be
    stimulated
  • glaucoma, acute globe injury
  • psychosis
  • thyroid disorder

36
Pre-sedationHistory
  • General health
  • Risk factors for sedation
  • Current medications
  • Allergies
  • Previous anesthetic reactions
  • patient / patients family
  • Why is sedation required?
  • Medications to be used

37
ASA Physical Status
  • Class I Healthy patient
  • Class II Systemic disease
  • Class III Severe systemic disease
  • Class IV Severe systemic disease that is a
    constant threat to life
  • Class V Moribund / not expected to
  • survive without surgery

38
  • In general, consider anesthesia or critical care
    involvement in patients that are ASA Class III or
    above and are not in the PICU

39
Pre-sedationPhysical Examination
  • Neurologic exam
  • Airway exam
  • Respiratory status
  • Cardiovascular exam

40
Personnel Responsibilities
  • Evaluation
  • Monitoring
  • Familiarity with medications
  • Anticipation of side effects
  • Resuscitation

41
MonitoringGeneral considerations
  • Heart Rate, Respiratory Rate, Blood Pressure
  • Continuous pulse oximetry
  • ECG
  • Perfusion
  • Neurologic status
  • State of consciousness
  • Pupillary responses

42
Discharge after Sedation for Short Procedure
  • Ability to sit unassisted or flex their neck
  • Verbal responses appropriate for age
  • Protective airway reflexes intact
  • Hemodynamic stability
  • Spontaneous breathing/good oxygenation
  • The patient has returned to their pre-sedation
    level of function

43
Neuromuscular Blockade
  • Achieves profound weakness of striated muscle
    without affecting the function of the cerebral
    cortex, smooth muscle or the myocardium.

44
Neuromuscular Blockade
  • NEVER muscle relax a patient without assuring
    adequate sedation/analgesia beforehand.
  • ALWAYS confirm the patient is easily
    hand-bag-ventilated prior to paralyzing

45
MonitoringMuscle Relaxants
  • Progression of weakness
  • small rapidly moving muscles of the
    fingers and eyes
  • muscles of the neck, limbs and trunk
  • muscles of respiration
  • Recovery occurs in reverse order the diaphragm
    recovers first

46
MonitoringMuscle Relaxants
  • Nerve stimulators
  • Stimulate nerve causing contraction of the
    corresponding muscle
  • Train-of-four monitoring
  • 1 out of 4 twitches 90 receptor blockade
  • Fade
  • Absent muscular response

47
MonitoringMuscle Relaxants
  • Clinical monitoring
  • Negative inspiratory force
  • Flexion of neck muscles
  • Infants
  • Hand grasp
  • Grimace
  • Flexion of hips

48
Muscle Relaxants
  • Cause weakness followed by a flaccid paralysis
  • Depolarizing muscle relaxants
  • Stimulate motor nerve endings
  • Non-depolarizing muscle relaxants
  • Compete at receptor site
  • All cause diaphragmatic paralysis

49
Muscle RelaxantsDepolarizing Agents
  • Imitate the affects of acetylcholine
  • Initial fasciculations followed by paralysis
  • Prevent repolarization of the muscle membrane
  • Quick onset
  • Succinylcholine is the only depolarizing muscle
    relaxant in clinical use

50
Succinylcholine adverse effects
  • Profound bradycardia
  • Hyperkalemia
  • Increased intracranial and ocular pressure
  • Hypersensitivity reactions
  • Muscle pains
  • Malignant hyperthermia
  • Rhabdomyolysis

51
Succinylcholine
  • Contraindications
  • Patients with paraplegia
  • following strokes or burns
  • muscular dystrophies, myotonia
  • patients with a family history of malignant
    hyperthermia.

52
Muscle RelaxantsNon-depolarizing Agents
  • Competitively inhibit the binding of
    acetylcholine
  • Most are steroid based

53
Pancuronium
  • Non-depolarizing
  • Tachycardia and hypertension due to muscarinic
    cholinergic blockage
  • Renal elimination

54
Vecuronium
  • Non-depolarizing
  • No cardiovascular effects
  • More expensive than pancuronium
  • Hepatic elimination

55
Atracurium and Cisatracurium
  • Non-depolarizing
  • Short duration
  • Best to use as continuous infusion
  • Hofmann elimination
  • Ideal agent in hepatorenal failure

56
Summary
  • The hospital and especially the PICU are scary
    places for children. Therefore, the use of
    anxiolytics and analgesics to facilitate
    procedures and medical therapies is key to the
    proper care of the child.

57
Summary
  • Safe use of sedatives requires knowledge of the
    medication used as well as close observation and
    monitoring of the child throughout the period of
    altered consciousness.

58
Summary
  • When muscle relaxation is necessary, confirm that
    the child is adequately sedated and able to be
    ventilated manually prior to administering a
    paralyzing agent.
Write a Comment
User Comments (0)
About PowerShow.com